Skip to main content
Clinical Trials/NCT06158204
NCT06158204
Active, not recruiting
Not Applicable

A Randomized Controlled Crossover Lifestyle Intervention to Improve Metabolic & Mental Health in Female Healthcare Night Shift Workers

Auburn University1 site in 1 country13 target enrollmentJanuary 2, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep, Inadequate
Sponsor
Auburn University
Enrollment
13
Locations
1
Primary Endpoint
Visceral fat percentage
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

Circadian rhythm disruption caused by shift work alters metabolic and hormonal pathways, which accelerates chronic disease onset, leading to decreased quality and quantity of life. Preclinical studies indicate that optimizing nutrient and sleep/rest timing can mitigate these effects.

Female nightshift healthcare workers will be recruited to participate in a randomized crossover trial in which participants will be expected to follow the prescribed lifestyle intervention for eight weeks during the first or second eight-week periods of the study.

Detailed Description

Clinical assessments will include DEXA, phlebotomy, questionnaires, and stool collection, which will be completed at weeks 0, 8, and 16 to assess changes in metabolic health and quality of life. Four days of 24-hour dietary recalls will be collected at baseline, and weeks 4, 8, 12, and 16. Garmin Vivofit4 activity trackers will be provided to all participants at baseline, and participants will be reminded to sync the devices once weekly at minimum. During the 8-week intervention phase, participants will receive guidance on when and what to eat and when to sleep and be physically active. Additionally, participants will be provided with whey protein isolate powder and grain-based snack bars to be consumed primarily during work shifts. Lean body mass (kg) will be used to prescribe total caloric (\~30kcal/kg lean mass) and protein (2g/kg lean mass) needs and sleep/rest goals will be 6-8 hours per 24 hour "day."

Registry
clinicaltrials.gov
Start Date
January 2, 2024
End Date
March 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andrew Fruge

Associate Professor

Auburn University

Eligibility Criteria

Inclusion Criteria

  • 18-50 years old
  • BMI between 27 and 40 kg/m2
  • \>6 months in current predominantly night shift (average 30+ hours/week) schedule
  • Can read and speak English
  • Willing to correspond with study staff using smartphone technologies

Exclusion Criteria

  • Pregnant or undergoing hormonal treatment for fertility
  • Major changes in any prescription medications within 3 months
  • Major surgeries in last 3 months
  • Diagnosis of Type 2 Diabetes or other major endocrine diseases
  • Diagnosed food allergies or significant dietary limitations
  • Currently engaged in intensive weight loss program
  • Minimal medically necessary radiation exposure within the last year

Outcomes

Primary Outcomes

Visceral fat percentage

Time Frame: Change from 0-8 weeks; 8-16 weeks

Change in visceral fat as a percentage of total fat mass as measured by dual x-ray absorptiometry. Lower values are optimal.

Mental Quality of Life

Time Frame: Change from 0-8 weeks; 8-16 weeks

Research ANd Development (RAND) Short Form-12 will assess mental quality of life (Range 0-100; 100 is optimal).

Physical Quality of Life

Time Frame: Change from 0-8 weeks; 8-16 weeks

Research ANd Development (RAND) Short Form-12 will assess physical quality of life (Range 0-100; 100 is optimal).

Secondary Outcomes

  • Fasting alanine aminotransferase (ALT)(Change from 0-8 weeks; 8-16 weeks)
  • Total protein intake(Change from 0-8 weeks; 8-16 weeks)
  • Fasting serum low-density lipoproteins (LDL)(Change from 0-8 weeks; 8-16 weeks)
  • Sleep - accelerometry(Change from 0-8 weeks; 8-16 weeks)
  • Stool microbiome composition(Change from 0-8 weeks; 8-16 weeks)
  • Fasting serum triglycerides(Change from 0-8 weeks; 8-16 weeks)
  • Fasting serum blood glucose(Change from 0-8 weeks; 8-16 weeks)
  • Total caloric intake(Change from 0-8 weeks; 8-16 weeks)

Study Sites (1)

Loading locations...

Similar Trials